Consolidated Statement of Operations - USD ($)	3 Months Ended		6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020
Details
Revenues	$ 1,461,844	$ 3,178,742	$ 3,159,765	$ 7,404,058
Cost of expenses:
Cost of revenues	565,451	2,421,113	1,135,124	4,707,180
Research and development expenses	53,251	103,394	100,883	215,697
Selling, general, and administrative expenses	635,965	2,292,416	1,314,784	4,460,766
Impairment charges	0	9,874,281	0	9,874,281
Operating Expenses	1,254,667	14,691,204	2,550,791	19,257,924
Income/(Loss) from operations	207,177	(11,512,462)	608,974	(11,853,866)
Interest expense - related party	257,713	218,629	524,113	428,915
Income/(Loss) before income taxes	(50,536)	(11,731,091)	84,861	(12,282,781)
Provision for income taxes	0	0	0	31,560
Net income/(loss)	$ (50,536)	$ (11,731,091)	$ 84,861	$ (12,314,341)
Net income/(loss) per common share - basic	$ (0.01)	$ (1.52)	$ 0.01	$ (1.60)
Net income/(loss) per common share - diluted	$ (0.01)	$ (1.52)	$ 0.01	$ (1.60)
Weighted average number of common shares outstanding - basic	7,712,091	7,712,091	7,712,091	7,709,014
Weighted average number of common shares outstanding - diluted	7,712,091	7,712,091	7,712,091	7,709,014